Skip to main content
. 2019 Mar 12;46(6):423–430. doi: 10.1159/000495773

Fig. 6.

Fig. 6

Reactivity of screening cells with plasma from patients with an anti-E or anti-K alloantibody without or spiked with 500 mg/L DARA. Lower figures show screening cells incubated with 15 µL DARA-Fab and patient's plasma containing an anti-E or anti-K alloantibody and 500 mg/L DARA. DARA-Fab incubation does not interfere with recognition of alloantibodies.